Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Working in Tandem: Effective Security for Weight-loss Drug Packaging
Navigating Global CDMO Trends
Anti-Counterfeiting Technology
Making the Most of Real-World Data in Clinical Trials
Inflation Reduction Act and the Impact on Biosimilars
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
BMS 1Q: Opdivo Sales Down 10%, Announces Restructuring Initiative
Pfizer’s BEQVEZ Approved by FDA for Treatment of Adults with Hemophilia B
Abzena Introduces Enhanced Bioassay Platform
Fujifilm & Predictive Oncology Tackle Protein Interference
Regeneron & Mammoth Partner on CRISPR Therapies
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
[WEBINAR] Mitigating Supply Chain Risks in an Age of Disruption
Multiply Labs and GenScript Partner to Automate Cell Isolation
FibroBiologics Discusses Opportunities to Work with Charles River
Lilly Acquires Manufacturing Facility from Nexus Pharmaceuticals
Hanmi, Merck Enter Clinical Collaboration & Supply Agreement
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
[WEBINAR] Mitigating Supply Chain Risks in an Age of Disruption
Tower Cold Chain Introduces KTEvolution 12 Containers
Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing
[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Abzena Introduces Enhanced Bioassay Platform
Fujifilm & Predictive Oncology Tackle Protein Interference
Regeneron & Mammoth Partner on CRISPR Therapies
Parexel, Palantir Expand AI Alliance
Ascend Taps Scott Law as COO
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
TATAA Biocenter Awarded GLP Accreditation
Anti-Counterfeiting Technology
Do You Know Your Product's Impurity Profile?
Inflation Reduction Act and the Impact on Biosimilars
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
August Bioservices
INCOG BioPharma Services
Solvias USA, LLC
Syngene International Ltd.
AMERIPHARMA
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
August Bioservices
INCOG BioPharma Services
Solvias USA, LLC
Syngene International Ltd.
AMERIPHARMA
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Financial Reports
All News
Bio News
Breaking News
Collaborations & Alliances
CRO News
Custom Sourcing News
Financial Reports
Industry News
Packaging & Tracking
Pharma Matters Q&A
Promotions & Moves
Reader Showcase
Trials & Filings
VideoBites
Financial Reports
BioNTech 4Q Earnings Hit by Drop in Covid Vax Sales
Inventory write-downs by partner Pfizer reduced revenues by €291.3 million in the quarter and €906.7 million for the year.
03.20.24
Financial Reports
Pharma & Biopharma 4Q Financials At A Glance
Steep decline in COVID product sales impacts results in the quarter.
Online Exclusives
02.27.24
Breaking News
|
Financial Reports
Moderna 4Q Results
Drop in COVID-19 vaccine sales impacts results.
02.22.24
Breaking News
|
Financial Reports
Catalent 2Q Results
Biologics revenue was $446 million in the quarter, down 23%, primarily impacted by a decline in demand for COVID-19 related programs.
02.16.24
Breaking News
|
Financial Reports
Gilead 4Q Results
Product sales were down due to lower Veklury and HIV sales, partially offset by higher Oncology sales.
02.07.24
Breaking News
|
Financial Reports
Merck 4Q Growth Driven by Oncology, Vaccines
Partially offset by a decline in virology, due to COVID-19 vaccine LAGEVRIO, and in diabetes due to JANUVIA.
02.05.24
Breaking News
|
Financial Reports
AbbVie 4Q Sales Down Due to Humira Competition
Global Humira sales were down 41% to $3.3 billion in the quarter.
02.05.24
Breaking News
|
Financial Reports
Bristol Myers Squibb 4Q Revenues up 1%
Higher sales of new product portfolio, as well as Eliquis and Opdivo sales, were partially offset by lower sales of Revlimid.
02.02.24
Breaking News
|
Financial Reports
J&J 4Q Revenues up 7%
Growth driven by DARZALEX, ERLEADA, TECVAYLI, CARVYKTI, STELARA, TREMFYA, and SPRAVATO.
02.01.24
Breaking News
|
Financial Reports
Novartis Revenues up 8% in the Quarter
Growth was mainly driven by Entresto, Kesimpta, Kisqali, Pluvicto and Scemblix.
02.01.24
Breaking News
|
Financial Reports
Sanofi 4Q Revenues up 2%
Dupixent and newly launched RSV vaccine Beyfortus help offset 74% decline in Aubagio sales due to generic competition.
02.01.24
Breaking News
|
Financial Reports
Pfizer 4Q Revenues Down 41%
Decline in Comirnaty and Paxlovid revenues drove 42% operational decrease in the quarter.
01.31.24
Breaking News
|
Financial Reports
Moderna Reports 3Q $3.6B Loss
Spikevax (COVID-19 vaccine) sales in the quarter were down 44% to $1.8 billion while R&D expenses increase 41% to $1.2 billion.
11.02.23
Breaking News
|
Financial Reports
Mounjaro Drives 3Q Revenue Growth for Lilly
Earnings impacted by IPR&D charges of $2.98 billion and sale of rights for the olanzapine portfolio.
11.02.23
Breaking News
|
Financial Reports
IQVIA 3Q Results
Research & Development Solutions revenue up 7% to $2.1 billion.
11.01.23
Breaking News
|
Financial Reports
Pfizer Revenues Down 42% in the Quarter and YTD
Continued drop in Paxlovid and Comirnaty sales globally impact results.
10.31.23
Breaking News
|
Financial Reports
Emergent BioSolutions 2Q Financial Results
NARCAN and Smallpox MCM sales drive revenue growth in the quarter.
08.09.23
Breaking News
|
Financial Reports
Pfizer 2Q Revenues Drop 54%
Primary Care revenues were down 72% primarily due to the drop in global Paxlovid and Comirnaty revenues.
08.01.23
Drug Development
|
Financial Reports
|
Industry News
2023 Top 10 Pharma & Biopharma Preview
A by the numbers look into Contract Pharma's Top Companies Report.
Online Exclusives
06.13.23
Breaking News
|
Financial Reports
Catalent 3rd Quarter Results
Revenues down 19% to $1.04 billion, while costs associated with Consumer Health unit contribute to loss of $227 million in the quarter.
06.12.23
Breaking News
BMS 1Q: Opdivo Sales Down 10%, Announces Restructuring Initiative
Pfizer’s BEQVEZ Approved by FDA for Treatment of Adults with Hemophilia B
Abzena Introduces Enhanced Bioassay Platform
Fujifilm & Predictive Oncology Tackle Protein Interference
Regeneron & Mammoth Partner on CRISPR Therapies
View Breaking News >
CURRENT ISSUE
April 2024
Anti-Counterfeiting Technology
Navigating Global CDMO Trends
Weight-loss Drug Packaging
Clinical Supply CDMOs
Industry Experts Weigh in on Oral Solid Dosage
Newsmakers Q&A: Almac Group
Economical Mobile Workstations for Lower-Grade Cleanrooms
Pharmaceutical Manufacturing Equipment & Trends
Insight Into Obesity-Related Clinical Research
Inflation Reduction Act and the Impact on Biosimilars
View More >